Cerus Corp (CERS)
1.755
-0.04
(-2.50%)
USD |
NASDAQ |
Nov 07, 16:00
1.78
+0.02
(+1.42%)
After-Hours: 20:00
Cerus Revenue (Annual): 156.37M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 156.37M |
| December 31, 2022 | 162.05M |
| December 31, 2021 | 130.86M |
| December 31, 2020 | 91.92M |
| December 31, 2019 | 74.65M |
| December 31, 2018 | 60.91M |
| December 31, 2017 | 43.57M |
| December 31, 2016 | 37.18M |
| December 31, 2015 | 34.22M |
| December 31, 2014 | 36.42M |
| December 31, 2013 | 39.66M |
| December 31, 2012 | 36.70M |
| December 31, 2011 | 30.60M |
| December 31, 2010 | 21.68M |
| Date | Value |
|---|---|
| December 31, 2009 | 17.98M |
| December 31, 2008 | 16.51M |
| December 31, 2007 | 11.04M |
| December 31, 2006 | 30.31M |
| December 31, 2005 | 24.37M |
| December 31, 2004 | 13.91M |
| December 31, 2003 | 9.665M |
| December 31, 2002 | 8.49M |
| December 31, 2001 | 4.535M |
| December 31, 2000 | 1.851M |
| December 31, 1999 | 2.408M |
| December 31, 1998 | 2.903M |
| December 31, 1997 | 6.90M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
74.65M
Minimum
2019
162.05M
Maximum
2022
123.17M
Average
130.86M
Median
2021
Revenue (Annual) Benchmarks
| Haemonetics Corp | 1.309B |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 43.60M |
| Xtant Medical Holdings Inc | 91.30M |
| Catheter Precision Inc | 0.442M |